Inflammatory bowel disease and risk of small bowel cancer: a binational population-based cohort study from Denmark and Sweden

Objective Crohn’s disease (CD) is associated with increased risk of small bowel cancer (SBC), but previous studies have been small. We aimed to examine the risk of incident SBC and death from SBC in patients with inflammatory bowel disease (IBD). Design In a binational, population-based cohort study from Sweden and Denmark of patients with IBD during 1969–2017 and matched reference individuals from the general population, we evaluated the risk of incident SBC and death from SBC. Cox regression was used to estimate adjusted hazard ratios (aHRs). Results We identified 161 896 individuals with IBD (CD: 47 370; UC: 97 515; unclassified IBD: 17 011). During follow-up, 237 cases of SBC were diagnosed in patients with IBD (CD: 24.4/100 000 person-years; UC: 5.88/100 000 person-years), compared with 640 cases in reference individuals (2.81/100 000 person-years and 3.32/100 000 person-years, respectively). This corresponded to one extra case of SBC in 385 patients with CD and one extra case in 500 patients with UC, followed up for 10 years. The aHR for incident SBC was 9.09 (95% CI 7.34 to 11.3) in CD and 1.85 (95% CI 1.43 to 2.39) in UC. Excluding the first year after an IBD diagnosis, the aHRs for incident SBC decreased to 4.96 in CD and 1.69 in UC. Among patients with CD, HRs were independently highest for recently diagnosed, childhood-onset, ileal and stricturing CD. The relative hazard of SBC-related death was increased in both patients with CD (aHR 6.59, 95% CI 4.74 to 9.15) and patients with UC (aHR 1.57; 95% CI 1.07 to 2.32). Conclusion SBC and death from SBC were more common in patients with IBD, particularly among patients with CD, although absolute risks were low.

[1]  R. Bleday,et al.  Small Bowel Adenocarcinoma: Is there a difference in survival for Crohn's versus Sporadic cases? , 2020, Journal of Crohn's & colitis.

[2]  Y. Toiyama,et al.  Cumulative burden of inflammation predicts colorectal neoplasia risk in ulcerative colitis: a large single-centre study. , 2019 .

[3]  J. Ludvigsson,et al.  Changes in inflammatory bowel disease subtype during follow-up and over time in 44,302 patients , 2019, Scandinavian journal of gastroenterology.

[4]  A. Hart,et al.  Cumulative burden of inflammation predicts colorectal neoplasia risk in ulcerative colitis: a large single-centre study , 2017, Gut.

[5]  O. Nielsen,et al.  Inflammatory Bowel Disease and Small Bowel Cancer Risk, Clinical Characteristics, and Histopathology: A Population‐Based Study , 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[6]  M. Neovius,et al.  Childhood onset inflammatory bowel disease and risk of cancer: a Swedish nationwide cohort study 1964-2014 , 2017, British Medical Journal.

[7]  Rickard Ljung,et al.  Validating inflammatory bowel disease (IBD) in the Swedish National Patient Register and the Swedish Quality Register for IBD (SWIBREG) , 2017, Scandinavian journal of gastroenterology.

[8]  M. Hernán,et al.  The continuing uncertainty about cancer risk in inflammatory bowel disease , 2016, Gut.

[9]  K. Michaëlsson,et al.  Registers of the Swedish total population and their use in medical research , 2016, European Journal of Epidemiology.

[10]  Sigrun Alba Johannesdottir Schmidt,et al.  The Danish National Patient Registry: a review of content, data quality, and research potential , 2015, Clinical epidemiology.

[11]  Laurent Beaugerie,et al.  Cancers complicating inflammatory bowel disease. , 2015, The New England journal of medicine.

[12]  Ashwin N. Ananthakrishnan,et al.  Epidemiology and risk factors for IBD , 2015, Nature Reviews Gastroenterology &Hepatology.

[13]  P. gordon,et al.  Small bowel adenocarcinoma and Crohn's disease: any further ahead than 50 years ago? , 2014, World journal of gastroenterology.

[14]  S. Vermeire,et al.  Small Bowel Adenocarcinomas Complicating Crohn's Disease Are Associated With Dysplasia: A Pathological and Molecular Study , 2014, Inflammatory bowel diseases.

[15]  Henrik Toft Sørensen,et al.  The Danish Civil Registration System as a tool in epidemiology , 2014, European Journal of Epidemiology.

[16]  E. Horváth-Puhó,et al.  Cancer Risk in Inflammatory Bowel Disease According to Patient Phenotype and Treatment: A Danish Population-Based Cohort Study , 2013, The American Journal of Gastroenterology.

[17]  F. Carrat,et al.  Incidence, Presentation, and Prognosis of Small Bowel Adenocarcinoma in Patients with Small Bowel Crohn's Disease: A Prospective Observational Study , 2013, Inflammatory bowel diseases.

[18]  F. Carrat,et al.  Risk of colorectal high-grade dysplasia and cancer in a prospective observational cohort of patients with inflammatory bowel disease. , 2013, Gastroenterology.

[19]  B. V. Pedersen,et al.  Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years. , 2012, Gastroenterology.

[20]  K. Helweg-larsen.  The Danish Register of Causes of Death , 2011, Scandinavian journal of public health.

[21]  Marianne Lundkjær Gjerstorff,et al.  The Danish Cancer Registry , 2011, Scandinavian journal of public health.

[22]  Elsebeth Lynge,et al.  The Danish National Patient Register , 2011, Scandinavian journal of public health.

[23]  J. Ludvigsson,et al.  External review and validation of the Swedish national inpatient register , 2011, BMC public health.

[24]  S. Itzkowitz,et al.  Intestinal inflammation and cancer. , 2011, Gastroenterology.

[25]  J. Liff,et al.  Crohn's Disease and Small Bowel Adenocarcinoma: A Population-Based Case–Control Study , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[26]  Norbert Senninger,et al.  Intestinal Cancer Risk in Crohn’s Disease: A Meta-Analysis , 2011, Journal of Gastrointestinal Surgery.

[27]  S. Devesa,et al.  Small Intestinal Cancer: a Population-Based Study of Incidence and Survival Patterns in the United States, 1992 to 2006 , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[28]  J. Ludvigsson,et al.  The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research , 2009, European Journal of Epidemiology.

[29]  C. Ko,et al.  Small Bowel Cancer in the United States: Changes in Epidemiology, Treatment, and Survival Over the Last 20 Years , 2009, Annals of surgery.

[30]  L. Holmberg,et al.  The completeness of the Swedish Cancer Register – a sample survey for year 1998 , 2009, Acta oncologica.

[31]  J. Beebe-Dimmer,et al.  The epidemiology and pathogenesis of neoplasia in the small intestine. , 2009, Annals of epidemiology.

[32]  K. Hemminki,et al.  Cancer risks in ulcerative colitis patients , 2008, International journal of cancer.

[33]  Lesly A. Dossett,et al.  Small Bowel Adenocarcinoma Complicating Crohn's Disease: Case Series and Review of the Literature , 2007, The American surgeon.

[34]  D. Schwartz,et al.  Carcinoid tumors are 15 times more common in patients with Crohn's disease , 2007, Inflammatory bowel diseases.

[35]  A. Darzi,et al.  The Risk of Cancer in Patients with Crohn’s Disease , 2007, Diseases of the colon and rectum.

[36]  J. Satsangi,et al.  The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications , 2006, Gut.

[37]  L. Melton,et al.  Risk of intestinal cancer in inflammatory bowel disease: a population-based study from olmsted county, Minnesota. , 2006, Gastroenterology.

[38]  E. Feuer,et al.  SEER Cancer Statistics Review, 1975-2003 , 2006 .

[39]  T. Sørensen,et al.  Increased Risk of Intestinal Cancer in Crohn's Disease: A Meta-Analysis of Population-Based Cohort Studies , 2005, The American Journal of Gastroenterology.

[40]  B. Bonaz,et al.  Small Bowel Adenocarcinoma in Patients with Crohn's Disease Compared with Small Bowel Adenocarcinoma De Novo , 2005, Inflammatory bowel diseases.

[41]  A. Whittemore,et al.  Incidence of Small Bowel Cancer in the United States and Worldwide: Geographic, Temporal, and Racial Differences , 2005, Cancer Causes & Control.

[42]  P. Munkholm,et al.  Intestinal and extra‐intestinal cancer in Crohn's disease: follow‐up of a population‐based cohort in Copenhagen County, Denmark , 2004, Alimentary pharmacology & therapeutics.

[43]  A. Zinsmeister,et al.  Small Intestinal Adenocarcinoma in Crohn's Disease: A Case-Control Study , 2004, Inflammatory bowel diseases.

[44]  J. Olsen,et al.  Crohn's disease and cancer risk (Denmark) , 2000, Cancer Causes & Control.

[45]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.

[46]  P. Dickman,et al.  Family history as a risk factor for colorectal cancer in inflammatory bowel disease. , 2001, Gastroenterology.

[47]  K. Abrams,et al.  The risk of colorectal cancer in ulcerative colitis: a meta-analysis , 2001, Gut.

[48]  E. Kliewer,et al.  Cancer risk in patients with inflammatory bowel disease , 2001, Cancer.

[49]  F. Michelassi,et al.  Adenocarcinoma at a strictureplasty site in Crohn's disease , 2001, Diseases of the colon and rectum.

[50]  J. Goldblum,et al.  Intestinal adenocarcinoma in Crohn's disease: a report of 30 cases with a focus on coexisting dysplasia. , 1999, The American journal of surgical pathology.

[51]  G. Testa,et al.  Adenocarcinoma complicating Crohn's disease , 1993, Diseases of the colon and rectum.

[52]  B. Lashner.  Risk factors for small bowel cancer in Crohn's disease , 1992, Digestive diseases and sciences.

[53]  D. Sachar,et al.  Small bowel carcinoma in crohn's disease. Distinguishing features and risk factors , 1989, Cancer.